SPOTLIGHT -
meningitis, steroids, FDA, CDC, compounding
Amneal Recalls 4 Lots of Vancomycin Because of Overfilling
The recommended maximum daily dose of Vancomycin is up to 2 grams a day. The overfilled vials could result in patients receiving up to 4 grams a day.
ICER to Shine a Light on Clinical Trial Diversity
Foluso Agboola discusses the framework that the Institute for Clinical and Economic Review has developed for assessing whether clinical trial populations represent the real-world patient population.
FDA Approves Vemlidy for Children with Hepatitis B
Vemlidy is now approved to treat patients 6 years and older with chronic hepatitis B virus infection.
FDA Approves Vafseo for Anemia in Kidney Disease
Vafseo, an oral therapy to treat patients with anemia due to chronic kidney, will be available in January 2025. About 40% of patients who could be treated with Vafseo have coverage through Medicare Advantage plans.
Medicare’s Spending on Ozempic and Other GLP-1s Rises Steeply
Ozempic and Rybelsus could become a target for Medicare price negotiation because of high spending and additional approved uses of the GLP-1 therapies.
AllianceRx Walgreens Pharmacy Selected to Distribute Vivjoa
Vivjoa is an azole antifungal to reduce the incidence of chronic vaginal yeast infection in postmenopausal women.